AI-10-49 | m-entrepreneurship.com

Product Name :
AI-10-49

Search keywords :
MYH11

drugId :
null

Target Vo:
CBFβ-SMMHC Fusion Protein

Target Vo Short Name :
CBFβ-SMMHC

Moa_Name:
CBFβ-SMMHC Fusion Protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
University Of Massachusetts Medical School

Active Company_Name :
University Of Massachusetts Medical School

Active Indication_Name:
Leukemia, Myeloid, Acute

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
PAX6 Antibody
Phospho-c-Myc (Ser62) Antibody
ICAM1 Antibody (YA725): ICAM1 Antibody (YA725) is a non-conjugated and Mouse origined monoclonal antibody about 58 kDa, targeting to ICAM1. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts